Clarivate (NYSE:CLVT) Shares Up 6.7% - Still a Buy?

Key Points

• Clarivate shares jumped 6.7% intraday to $2.976, but trading was very light at 224,744 shares—about 97% below average—so the move lacked strong volume support.
• Analyst sentiment is broadly negative: multiple downgrades and price cuts have left a consensus rating of "Reduce" and a consensus target price of $3.22.
• Recent results were mixed — Clarivate beat quarterly EPS ($0.18 vs. $0.14) and revenue ($585.5M vs. $569.5M) and guided FY2026 EPS to $0.70–$0.80, but it still reports a negative net margin and sub-1.0 liquidity ratios.

Clarivate PLC (NYSE:CLVT - Get Free Report)'s stock price shot up 6.7% on Monday . The stock traded as high as $2.92 and last traded at $2.9760. 224,744 shares changed hands during mid-day trading, a decline of 97% from the average session volume of 6,817,749 shares. The stock had previously closed at $2.79.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CLVT. Royal Bank Of Canada cut their price objective on shares of Clarivate from $5.00 to $3.00 and set a "sector perform" rating on the stock in a research report on Wednesday, February 25th. Barclays cut their price objective on shares of Clarivate from $4.00 to $2.40 and set an "underweight" rating on the stock in a research report on Wednesday, February 25th. The Goldman Sachs Group downgraded shares of Clarivate from a "buy" rating to a "neutral" rating and cut their price objective for the company from $4.20 to $3.60 in a research report on Thursday, January 8th. Citigroup cut their price objective on shares of Clarivate from $4.25 to $2.80 and set a "neutral" rating on the stock in a research report on Wednesday, March 4th. Finally, Weiss Ratings reiterated a "sell (e+)" rating on shares of Clarivate in a research report on Friday, March 27th. Five investment analysts have rated the stock with a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, Clarivate has a consensus rating of "Reduce" and a consensus target price of $3.22.

Clarivate Price Performance

The company has a market capitalization of $1.84 billion, a P/E ratio of -13.69 and a beta of 1.41. The business's 50-day simple moving average is $2.47 and its 200 day simple moving average is $2.94. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 0.89.

Clarivate (NYSE:CLVT - Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 EPS for the quarter, topping analysts' consensus estimates of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The company had revenue of $585.50 million for the quarter, compared to the consensus estimate of $569.50 million. During the same period in the previous year, the firm earned $0.14 EPS. Clarivate's revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. As a group, sell-side analysts anticipate that Clarivate PLC will post 0.63 EPS for the current year.

Institutional Trading of Clarivate

A number of hedge funds and other institutional investors have recently made changes to their positions in CLVT. ARQ Wealth Advisors LLC bought a new stake in shares of Clarivate in the 1st quarter worth approximately $153,000. Sequoia Financial Advisors LLC increased its stake in Clarivate by 353.9% in the 1st quarter. Sequoia Financial Advisors LLC now owns 138,731 shares of the company's stock valued at $351,000 after buying an additional 108,168 shares during the period. Hsbc Holdings PLC increased its stake in Clarivate by 150.1% in the 1st quarter. Hsbc Holdings PLC now owns 133,788 shares of the company's stock valued at $337,000 after buying an additional 80,293 shares during the period. Range Financial Group LLC bought a new stake in Clarivate in the first quarter worth approximately $291,000. Finally, Personal CFO Solutions LLC bought a new stake in Clarivate in the first quarter worth approximately $30,000. 85.72% of the stock is currently owned by institutional investors.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters' Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.